About MDA

Fighting every day to free individuals — and the families who love them — from the harmful effects of muscle-debilitating diseases so they can live longer and grow stronger

Press Releases

  • MDA Awards $400,000 Grant to NIH for ALS Exome-Sequencing Project

    TUCSON, Ariz. — The Muscular Dystrophy Association announced today that it has awarded a $400,000 infrastructure grant to National Institutes of Health (NIH) researchers to support exome sequencing on samples taken from 1,000 people with amyotrophic lateral sclerosis (ALS).

  • Exciting Results in Duchenne MD Gene Therapy Study

    Study could mean technological breakthrough; MDA provided funding to the study's lead investigator

    TUCSON, Ariz. (Jan. 15, 2013) — The Muscular Dystrophy Association announced today that a microgene created to mimic the larger dystrophin gene missing in Duchenne muscular dystrophy (DMD) showed reduced inflammation and fibrosis, and also improved the muscle strength in a study conducted by University of Missouri scientists.

  • MDA Awards $10.7 Million in Grants

    TUCSON, Ariz., Aug. 21, 2012 — Greater understanding of the causes and natural histories of neuromuscular diseases, and translation of the latest research advances into potential treatments are the focus of new projects funded by the Muscular Dystrophy Association’s latest round of grants.

    MDA awarded 33 grants totaling $10,684,481 million. The grants became effective in August 2012.

  • Muscular Dystrophy Association and The ALS Association Fund Clinical Trial of Diaphragm Pacing System in People with ALS

    Trial Will Test Efficacy of NeuRx Diaphragm Pacing System in People with Lou Gehrig's Disease

     

  • MDA Launches 'Bridge-To-Industry' Pilot Project Innovative Program Facilitates Drug Developement and Trains Researchers in Translational Research

    TUCSON, Ariz. —The Muscular Dystrophy Association today announced the launch of its Bridge-to-Industry (B2I) program, a pilot project designed to train promising researchers in translational research by providing experience both in academia and the biopharmaceutical industry.

    Translational research refers to the lengthy and complex “translation” of promising laboratory findings into marketable drugs.

  • MDA Awards more than $12 Million in Grants

     

    TUCSON, Ariz. — The Muscular Dystrophy Association’s latest round of grants allocates more than $12 million to the support of 38 research projects investigating the causes of, and potential treatments for, a number of forms of neuromuscular disease.

    “MDA is strongly committed to funding important and exciting basic research that will serve as the basis of future therapies for neuromuscular disease,” said MDA Chairman of the Board R. Rodney Howell, M.D. Howell is a professor of pediatrics in the Miller School of Medicine at the University of Miami (Fla.).